HRP20161465T8 - Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo - Google Patents

Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Info

Publication number
HRP20161465T8
HRP20161465T8 HRP20161465TT HRP20161465T HRP20161465T8 HR P20161465 T8 HRP20161465 T8 HR P20161465T8 HR P20161465T T HRP20161465T T HR P20161465TT HR P20161465 T HRP20161465 T HR P20161465T HR P20161465 T8 HRP20161465 T8 HR P20161465T8
Authority
HR
Croatia
Prior art keywords
high density
inorganic nanoparticles
density inorganic
vivo destruction
destruction
Prior art date
Application number
HRP20161465TT
Other languages
English (en)
Croatian (hr)
Inventor
Laurent Levy
Agnès Pottier
Annabelle Rouet
Julie Marill
Corinne Devaux
Matthieu Germain
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of HRP20161465T1 publication Critical patent/HRP20161465T1/hr
Publication of HRP20161465T8 publication Critical patent/HRP20161465T8/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/244Lanthanides; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HRP20161465TT 2008-06-05 2009-06-04 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo HRP20161465T8 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08157686A EP2130553A1 (fr) 2008-06-05 2008-06-05 Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo
US6020208P 2008-06-10 2008-06-10
EP09757595.5A EP2300054B1 (fr) 2008-06-05 2009-06-04 Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo
PCT/EP2009/056880 WO2009147214A2 (fr) 2008-06-05 2009-06-04 Nanoparticules inorganiques, leur préparation et leurs utilisations

Publications (2)

Publication Number Publication Date
HRP20161465T1 HRP20161465T1 (hr) 2017-01-27
HRP20161465T8 true HRP20161465T8 (hr) 2017-04-21

Family

ID=39734334

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20161465TT HRP20161465T8 (hr) 2008-06-05 2009-06-04 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo
HRP20181993TT HRP20181993T1 (hr) 2008-06-05 2018-11-27 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20181993TT HRP20181993T1 (hr) 2008-06-05 2018-11-27 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Country Status (26)

Country Link
US (1) US8845507B2 (fr)
EP (4) EP2130553A1 (fr)
JP (1) JP5734181B2 (fr)
KR (1) KR101639281B1 (fr)
CN (1) CN102056628B (fr)
AU (1) AU2009254550B2 (fr)
BR (1) BRPI0913410B1 (fr)
CA (1) CA2727576C (fr)
CY (2) CY1118217T1 (fr)
DK (2) DK3150227T3 (fr)
EA (1) EA023012B1 (fr)
ES (2) ES2702249T3 (fr)
HR (2) HRP20161465T8 (fr)
HU (2) HUE030669T2 (fr)
IL (1) IL209625A (fr)
LT (2) LT2300054T (fr)
MA (1) MA32453B1 (fr)
MX (1) MX2010013322A (fr)
NZ (1) NZ589888A (fr)
PL (2) PL3150227T3 (fr)
PT (2) PT2300054T (fr)
SG (1) SG10201405288WA (fr)
SI (2) SI2300054T1 (fr)
TR (1) TR201819077T4 (fr)
WO (1) WO2009147214A2 (fr)
ZA (1) ZA201100082B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070164238A1 (en) * 2003-02-24 2007-07-19 Pomper Mark E Mobile radiation treatment vehicle and method
US8657354B2 (en) 2006-05-19 2014-02-25 Breya, Llc. Mobile radiation therapy
US8459714B2 (en) 2006-05-19 2013-06-11 Breya, Llc. Mobile radiation therapy
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8728440B2 (en) 2012-08-23 2014-05-20 General Electric Company Nanoparticulate compositions for diagnostic imaging
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
EP2275137A1 (fr) 2009-07-10 2011-01-19 Nanobiotix Nanoparticules métalliques, leur préparation et utilisations
CN102870235B (zh) * 2009-11-10 2016-11-23 免疫之光有限责任公司 用于从包括用于上变频的射频、微波能量和磁感应源的各种能量源产生发射光的上下变频系统
WO2011133228A2 (fr) * 2010-04-23 2011-10-27 Pixelligent Technologies, Llc Synthèse, coiffage et dispersion de nanocristaux
EP3190083B1 (fr) 2010-10-27 2020-08-26 Pixelligent Technologies, LLC Synthèse, coiffage et dispersion de nanocristaux
US9359689B2 (en) 2011-10-26 2016-06-07 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
EA029635B1 (ru) 2011-12-16 2018-04-30 Нанобиотикс Применение наночастицы, включающей металлический материал, покрытый материалом оксида гафния, в онкологии и композиция, ее содержащая
AU2013274093A1 (en) * 2012-06-14 2014-12-18 Bioventures, Llc Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo
US8821838B2 (en) 2012-08-23 2014-09-02 General Electric Company Nanoparticulate compositions for diagnostic imaging
AR094577A1 (es) * 2013-01-25 2015-08-12 Nanobiotix Composiciones para el tratamiento de cáncer, preparación y usos de las mismas
KR101999421B1 (ko) * 2013-02-19 2019-07-11 내셔날 헬스 리서치 인스티튜트 항암 화학치료제를 위한 케이지된 백금 나노클러스터
WO2014191569A1 (fr) 2013-05-30 2014-12-04 Nanobiotix Composition pharmaceutique, préparation et utilisations de celle-ci
EA201690050A1 (ru) * 2013-06-20 2016-05-31 Нанобиотикс Композиции и способы для применения в медицинской диагностике
JP6671292B2 (ja) * 2013-12-16 2020-03-25 ジェネンテック, インコーポレイテッド ペプチド模倣化合物及びその抗体−薬物コンジュゲート
EP2886128A1 (fr) 2013-12-20 2015-06-24 Nanobiotix Compositions pharmaceutiques comportant des nanoparticules, leur préparation et leur utilisation
EP3229776B1 (fr) * 2014-11-25 2023-06-28 Curadigm Sas Composition pharmaceutique combinant au moins deux nanoparticules distinctes et un composé pharmaceutique, leur préparation et leurs utilisations
SG11201704143YA (en) 2014-11-25 2017-06-29 Nanobiotix Pharmaceutical composition, preparation and uses thereof
EP3223796B1 (fr) 2014-11-25 2021-07-21 Curadigm Sas Composition pharmaceutique, sa préparation et ses utilisations
ES2774365T3 (es) 2014-11-25 2020-07-20 Curadigm Sas Composición farmacéutica, preparación y usos de la misma
UA123665C2 (uk) 2014-11-25 2021-05-12 Кюрадігм Сас Фармацевтична композиція, її одержання і застосування
US20180008733A1 (en) * 2015-01-08 2018-01-11 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
UA124572C2 (uk) * 2015-05-28 2021-10-13 Нанобіотікс Наночастинки для застосування як терапевтичної вакцини
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN109616308B (zh) * 2018-11-07 2020-09-04 湖北第二师范学院 一种球形纳米氧化铱dna提取磁性粉末及其生产方法
CN109771645B (zh) * 2019-03-07 2021-08-24 广西师范大学 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用
KR20230038659A (ko) * 2020-05-26 2023-03-21 나노비오띡스 나노 입자, 전리 방사선 및 그의 혁신적인 치료용 조합
CN116507366A (zh) * 2020-11-05 2023-07-28 纳米生物技术公司 用于治疗癌症的纳米颗粒组合物
US20240000940A1 (en) * 2020-12-01 2024-01-04 Nanobiotix S.A. Porous, high-z and carbon-free particles as radioenhancers
AR131316A1 (es) 2022-12-12 2025-03-05 Nanobiotix S A Novedosas nanopartículas de óxido de metal y composiciones de las mismas para uso como radiopotenciadores o para visualizar tejido biológico
EP4595983A1 (fr) 2024-02-05 2025-08-06 BXTA Nanotherapy Limited Nanoparticules fonctionnalisées avec un agent stabilisant et un agent de ciblage
WO2026074471A1 (fr) * 2024-10-02 2026-04-09 Janssen Pharmaceutica Nv Polythérapies avec des nanoparticules d'oxyde d'hafnium et des anticorps pd-l1 destinés à être utilisés dans le traitement du cancer du poumon non à petites cellules

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287526A (ja) * 1985-10-11 1987-04-22 Akira Fujishima 抗腫瘍剤
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
EP1696957A2 (fr) 2003-12-17 2006-09-06 Philips Intellectual Property & Standards GmbH Radiotherapie et imagerie medicale au moyen de nanoparticules emettant des rayons ultraviolets
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070092927A1 (en) * 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
JP2007075696A (ja) * 2005-09-13 2007-03-29 Mitsubishi Materials Corp 多孔質光触媒膜
US20090191128A1 (en) * 2006-07-10 2009-07-30 Koninklijke Philips Electronics N.V. Core-shell nanoparticles for thearapy and imaging purposes
EP1920784A1 (fr) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Sensibilisateurs de radiation pour la thérapie par rayonnements ionisants et pour l'imagerie

Also Published As

Publication number Publication date
EP3150227A1 (fr) 2017-04-05
SI2300054T1 (sl) 2017-02-28
BRPI0913410A2 (pt) 2015-11-24
JP5734181B2 (ja) 2015-06-17
HUE040247T2 (hu) 2019-02-28
JP2011524866A (ja) 2011-09-08
PL2300054T3 (pl) 2017-04-28
SG10201405288WA (en) 2014-10-30
HUE030669T2 (en) 2017-05-29
ZA201100082B (en) 2011-10-26
AU2009254550B2 (en) 2013-10-24
CN102056628B (zh) 2013-07-10
US8845507B2 (en) 2014-09-30
EP2130553A1 (fr) 2009-12-09
EP3150227B1 (fr) 2018-10-31
KR20110028616A (ko) 2011-03-21
AU2009254550A1 (en) 2009-12-10
PL3150227T3 (pl) 2019-05-31
EP3461502A1 (fr) 2019-04-03
ES2702249T3 (es) 2019-02-28
MA32453B1 (fr) 2011-07-03
WO2009147214A3 (fr) 2010-02-25
MX2010013322A (es) 2011-01-21
PT3150227T (pt) 2018-12-24
CA2727576A1 (fr) 2009-12-10
NZ589888A (en) 2012-06-29
WO2009147214A2 (fr) 2009-12-10
BRPI0913410B1 (pt) 2021-09-21
CN102056628A (zh) 2011-05-11
CY1118217T1 (el) 2017-06-28
EA201071429A1 (ru) 2011-06-30
DK3150227T3 (en) 2019-01-14
IL209625A (en) 2015-11-30
EP2300054A2 (fr) 2011-03-30
LT3150227T (lt) 2018-12-10
PT2300054T (pt) 2016-11-11
HRP20161465T1 (hr) 2017-01-27
LT2300054T (lt) 2016-12-27
DK2300054T3 (en) 2016-12-05
IL209625A0 (en) 2011-02-28
EA023012B1 (ru) 2016-04-29
TR201819077T4 (tr) 2019-01-21
EP2300054B1 (fr) 2016-09-07
KR101639281B1 (ko) 2016-07-13
CY1121078T1 (el) 2019-12-11
ES2602048T3 (es) 2017-02-17
HRP20181993T1 (hr) 2019-01-25
CA2727576C (fr) 2016-08-16
SI3150227T1 (sl) 2019-02-28
US20110213192A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
HRP20161465T8 (hr) Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo
SMT201900049T1 (it) Composti eterociclici e loro utilizzi
PL3395876T3 (pl) Nowe nanocząstki
EP2401367A4 (fr) Transposases piggybac hyperactives
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
EP3988147C0 (fr) Ensemble d'insertion
BRPI0907884A2 (pt) Partícula de liberação
BRPI0909220A2 (pt) Partícula de liberação
EP2306992A4 (fr) Particule de vectorisation
FR2929464B1 (fr) Nano resonnateur magnetique
EP2264681A4 (fr) Alarme
HUE044194T2 (hu) Besugárzó berendezés
EP2486509A4 (fr) Sécurité de plateforme
EP2256707A4 (fr) Alarme
EP2387787A4 (fr) Nanoparticules magnétiques
EP2300238A4 (fr) Caractéristique de sécurité sous la forme d'une image fantôme
DE502009000614D1 (de) Anhängekupplung
EP2429699A4 (fr) Modification de la densité
EP2350385A4 (fr) Section de mise en forme
DK2506831T3 (da) Carboxyvinylpolymerholdige nanopartikelsuspensioner
SMT201500273B (it) Diidroetorfine e loro preparazione
DK2329319T3 (da) Forbedret nanoimprint fremgangsmåde
EP2481088A4 (fr) Nanoparticules passivées
EP2288449A4 (fr) Nanoparticules hybrides
DK2277578T3 (da) Forstøver